Vitualla, Erlie May R.
HRN: 23-16-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
06/18/2023
06/25/2023
TOPICAL
Apply Thinly On Affected Area
TID
Periorbital Hematoma, OS
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes